找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Mechanisms of Drug Resistance in Cancer Therapy; Mario Mandalà,Emanuela Romano Book 2018 Springer Nature Switzerland AG 2018 Drug resistan

[复制链接]
楼主: 非决定性
发表于 2025-3-26 21:36:41 | 显示全部楼层
发表于 2025-3-27 01:14:15 | 显示全部楼层
Targeting DNA Repair,anding of the molecular mechanisms through which the DNA damage response (DDR) operates, in combination with the elucidation of the genetic interactions between DDR pathways and other cell pathways, will provide therapeutic opportunities for the personalized medicine of cancer.
发表于 2025-3-27 06:44:12 | 显示全部楼层
Book 2018 rational therapeutic drug combinations and the use of predictive and prognostic biomarkers to enable patient stratification and tailor treatments. It offers to the readers an updated overview on the possible reasons of failure of new and promising therapeutic opportunities..
发表于 2025-3-27 12:11:17 | 显示全部楼层
0171-2004 f issues including pharmacodynamic and pharmacokinetic mecha.A major objective of this book is to reveal unprecedented opportunities to understand and overcome drug resistance through the clinical assessment of rational therapeutic drug combinations and the use of predictive and prognostic biomarker
发表于 2025-3-27 15:36:29 | 显示全部楼层
Molecular and Pharmacological Mechanisms of Drug Resistance:An Evolving Paradigm,asons and inefficient and heterogeneous tumor drug distribution, related to a deficient vascularization and high interstitial pressure. Finally, resistance can be related to the activation of anti-apoptotic and cell survival pathways by cancer cells and often enhanced by tumor microenvironment.
发表于 2025-3-27 18:30:23 | 显示全部楼层
Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid Leukemia,been identified, ranging from BCR-ABL1 kinase domain mutations to lack of adherence to therapy. In this review, we briefly summarize the clinical efficacy of approved TKIs and describe the main mechanisms of TKI resistance.
发表于 2025-3-28 00:28:17 | 显示全部楼层
发表于 2025-3-28 05:08:08 | 显示全部楼层
发表于 2025-3-28 09:57:40 | 显示全部楼层
Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer,transition). These basic mechanisms are informing the development of novel therapeutic strategies to overcome resistance in the clinic. Novel-generation molecules include osimertinib, for EGFR-T790M-positive patients, and new ALK-TKIs. Nevertheless, the possible concomitant presence of multiple resi
发表于 2025-3-28 13:30:54 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-23 17:27
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表